Skip to main content
Skip to "About government"
Skip to section menu
Language selection
Français
fr
/
Gouvernement du Canada
Search
Search Canada.ca
Search
Menu
Main
Menu
Jobs and the workplace
Immigration and citizenship
Travel and tourism
Business and industry
Benefits
Health
Taxes
Environment and natural resources
National security and defence
Culture, history and sport
Policing, justice and emergencies
Transport and infrastructure
Canada and the world
Money and finances
Science and innovation
Manage life events
You are here:
Canada.ca
Departments and agencies
Health Canada
Drugs and health products
Drug products
Scientific/Expert Advisory Panels
Scientific Advisory Panel on Opioid Use and Contraindications
Announcement of Meeting
Terms of Reference
2017-02-24
Membership
Membership List and Biographies
Summary of Expertise, Experience and Affiliations and Interests
Meetings
2017-03-24
Agenda
Questions for the Scientific Advisory Panel
Record of Proceedings
Page details
2017-08-30
Section Menu
Scientific/Expert Advisory Panels
Anti-infective Therapies
Bioequivalence Requirements for Gender-Specific Drug Products (GSDP)
ARCHIVED - Bioequivalence Requirements for Modified-Release Dosage Forms (SAP-MRDF)
ARCHIVED - Opioid Analgesic Abuse (OAA)
Scientific Advisory Panel on Opioid Use and Contraindications
Scientific Advisory Panel on Opioid Use and Contraindications (SAP-OUC)
Scientific Advisory Panel on Opioid Use and Contraindications (SAP-OUC)
Scientific Advisory Panel on Opioid Use and Contraindications (SAP-OUC)
Questions for the Scientific Advisory Panel on Opioid Use and Contraindications (SAP-OUC)
Scientific Advisory Panel on Opioid Use and Contraindications (SAP-OUC)
Summary of Expertise, Experience and Affiliations and Interests for the Scientific Advisory Panel on Opioid Use and Contraindications (SAP-OUC)
Scientific Advisory Panel on Opioid Use and Contraindications (SAP-OUC)
Scientific Advisory Panel on Opioids (SAP-Opioids)
Scientific/Expert Advisory Panels
